American Association for Cancer Research
Browse
00085472can202129-sup-245850_3_supp_6707324_qjhksx.xlsx (3.77 MB)

Supplementary Table 3 from Widespread Repression of Gene Expression in Cancer by a Wnt/β-Catenin/MAPK Pathway

Download (3.77 MB)
dataset
posted on 2023-03-31, 04:00 authored by Nathan Harmston, Jun Yi Stanley Lim, Oriol Arqués, Héctor G. Palmer, Enrico Petretto, David M. Virshup, Babita Madan

Supplementary Table 3

Funding

National Medical Research Council

History

ARTICLE ABSTRACT

Aberrant Wnt signaling drives a number of cancers through regulation of diverse downstream pathways. Wnt/β-catenin signaling achieves this in part by increasing the expression of proto-oncogenes such as MYC and cyclins. However, global assessment of the Wnt-regulated transcriptome in vivo in genetically distinct cancers demonstrates that Wnt signaling suppresses the expression of as many genes as it activates. In this study, we examined the set of genes that are upregulated upon inhibition of Wnt signaling in Wnt-addicted pancreatic and colorectal cancer models. Decreasing Wnt signaling led to a marked increase in gene expression by activating ERK and JNK; these changes in gene expression could be mitigated in part by concurrent inhibition of MEK. These findings demonstrate that increased Wnt signaling in cancer represses MAPK activity, preventing RAS-mediated senescence while allowing cancer cells to proliferate. These results shift the paradigm from Wnt/β-catenin primarily as an activator of transcription to a more nuanced view where Wnt/β-catenin signaling drives both widespread gene repression and activation. These findings show that Wnt/β-catenin signaling causes widespread gene repression via inhibition of MAPK signaling, thus fine tuning the RAS-MAPK pathway to optimize proliferation in cancer.

Usage metrics

    Cancer Research

    Licence

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC